Send feedback

AP3D1 p.Ala455Thr

c.1363G>A · rs200459002 · VCV988866

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 5 submitters
AlphaMissense
likely benign
0.2982 · ACMG-weighted
gnomAD v4.1
Rare
rare (popmax 0.108%, nfe)
Missense predictors
1/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
2
Hermansky-Pudlak syndrome 10

Computational evidence

Protein change
AlphaMissense0.2982likely benign
REVEL0.29benign-leaning
SaProtLLR -10.45damaging
⇒ SaProt calls this damaging; AlphaMissense and REVEL do not.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.6GERP 1.4, phastCons 1
Regional constrainto/e 0.80unconstrained · MANE · 4,612 bp · p 7.4e-05 · regional, not allelic
Overall
CADD23.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.108% European (non-Finnish) · 1,275/1,179,992 alleles
Filtering AF 0.103% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.101%
Overall 0.0889% 1,433/1,612,056 alleles · rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.199% 502
European (non-Finnish)grpmax 0.108% 925
Finnishnot grpmax-eligible 0.0662% 1,511
Remaining individualsnot grpmax-eligible 0.0592% 1,689
African / African-American 0.02% 5,004
Admixed American 0.00833% 12,006
South Asian 0.0011% 91,088

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
AP3D1
Protein
p.Ala455Thr
Coding
c.1363G>A
MANE Select
NM_001261826
dbSNP
rs200459002
Type
single nucleotide variant
Location
chr19:2120980 (GRCh38)
Gene constraint
LOEUF 0.443 · pLI 1.00 (gnomAD)
Structure
AlphaFold pLDDT 76.45 · 6 PDB
Full AP3D1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

Hermansky-Pudlak syndrome 10 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: thrombocytopenia

For Hermansky-Pudlak syndrome (Orphanet):

Inheritance
Autosomal recessive
Onset
Infancy, Neonatal
Prevalence
1-9 / 1 000 000 (Worldwide)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/ap3d1-p-ala455thr (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown